Emerging in the arena of obesity management, retatrutide presents a different method. Unlike many current medications, retatrutide works as a dual agonist, concurrently targeting both GLP peptide-1 (GLP-1) and glucose-responsive insulinotropic polypeptide (GIP) sensors. The concurrent activation fosters multiple advantageous effects, like enhanced … Read More